Healthy men test new version of arthritis drug in safety study
NCT ID NCT06262477
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 24 times
Summary
This study tested a new drug called BIIB800 against the approved drug Actemra in 300 healthy men. The goal was to see if the body processes both drugs similarly and to check for side effects. Participants received a single injection and were monitored over time. No treatment was given for any disease; the study was purely to gather safety and drug-level data.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fortrea Clinical Research Unit Inc.
Daytona Beach, Florida, 32117, United States
-
Fortrea Clinical Research Unit Inc.
Dallas, Texas, 75247, United States
-
Fortrea Clinical Research Unit Inc.
Madison, Wisconsin, 53704, United States
-
Fortrea Clinical Research Unit Inc.
Leeds, West Yorkshire, LS2 9LH, United Kingdom
Conditions
Explore the condition pages connected to this study.